NFL Biosciences SAS Cash Flow-to-Debt Ratio
NFL Biosciences SAS cash flow-to-debt ratio. NFL Biosciences SAS (ALNFL) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2023, meaning its operating cash flow of €57.51K could theoretically repay 0% of its total liabilities (€3.67 Million) in one year. See NFL Biosciences SAS (ALNFL) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of NFL Biosciences SAS (2020–2022)
Cash flow-to-debt ratio of NFL Biosciences SAS from 2020 to 2022. Historical debt coverage capacity for NFL Biosciences SAS across 3 annual periods. Check ALNFL cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
NFL Biosciences SAS Cash Flow-to-Debt Ratio by Year (2020–2022)
NFL Biosciences SAS cash flow-to-debt ratio by year from 2020 to 2022. Year-by-year debt coverage analysis for NFL Biosciences SAS. For the full cash flow conversion analysis, see NFL Biosciences SAS cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | 0.07x | €104.89K | €1.55 Million | ▼ -69.1% |
| 2021 | 0.22x | €87.00K | €397.73K | ▲ +11.2% |
| 2020 | 0.20x | €83.91K | €426.61K | — |